Thomas Hartung

1.
Emily Golden, David Allen, Alexander Amberg, et al. Toward implementing virtual control groups in nonclinical safety studies: Workshop report and roadmap to implementation. ALTEX - Alternatives to animal experimentation. 2023. doi:10.14573/altex.2310041
View Full Reference
1.
Thomas Hartung. ToxAIcology - The evolving role of artificial intelligence in advancing toxicology and modernizing regulatory science. ALTEX. 2023;40(4):559-570. doi:10.14573/altex.2309191
View Full Reference
1.
Breanne Kincaid, Przemyslaw Piechota, Emily Golden, Mikhail Maertens, Thomas Hartung, Alexandra Maertens. Using in silico tools to predict flame retardant metabolites for more informative exposomics-based approaches. Frontiers in Toxicology. 2023;5:1216802. doi:10.3389/ftox.2023.1216802
View Full Reference
1.
Thomas Hartung. Artificial intelligence as the new frontier in chemical risk assessment. Frontiers in Artificial Intelligence. 2023;6:1269932. doi:10.3389/frai.2023.1269932
View Full Reference
1.
Jean Knight, Thomas Hartung, Costanza Rovida. 4.2 million and counting… The animal toll for REACH systemic toxicity studies. ALTEX - Alternatives to animal experimentation. 2023;40(3):389-407. doi:10.14573/altex.2303201
View Full Reference
1.
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. The Journal of Infectious Diseases. 2023:jiad334. doi:10.1093/infdis/jiad334
View Full Reference
1.
Paula Barreras, David Pamies, Thomas Hartung, Carlos A. Pardo. Human brain microphysiological systems in the study of neuroinfectious disorders. Experimental Neurology. 2023;365:114409. doi:10.1016/j.expneurol.2023.114409
View Full Reference
1.
Costanza Rovida, Francois Busquet, Marcel Leist, Thomas Hartung. REACH out-numbered! The future of REACH and animal numbers. ALTEX - Alternatives to Animal Experimentation. 2023;40(3):367-388. doi:10.14573/altex.2307121
View Full Reference
1.
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
View Full Reference
1.
David Pamies, Marcel Leist, Sandra Coecke, et al. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). Alternatives to Animal Experimentation. 2022;39(1):30-70. doi:10.14573/altex.2111011
View Full Reference